NanoSight’s Nanoparticle Tracking Analysis in the Study of Exosomes.

Posted by

Technology Networks

One of the fastest growing applications for NanoSight’s nanoparticle tracking analysis is the study of exosomes. Work at the John Radcliffe Hospital in Oxford has shown a unique application for NTA as an early detector for biomarkers. Most researchers concur that the high levels of microvesicles and/or exosomes are associated with (i.e. potential biomarkers for) thrombotic diseases, cardiovascular disease and some cancers. Oxford team-leader, Professor Ian Sargent, has said that “NTA is a major step forward in analytical capability taking the limits of flow cytometry down almost an order of magnitude. It is rapid and characterizes polydispersity well.”